Skip to main content
. 2021 Jun 24;13(12):15770–15784. doi: 10.18632/aging.203159

Figure 3.

Figure 3

Survival analysis of cancer patients with differential gene expression level. (AD) Survival curve of SARC (n=259), CESC (n=304), TGCT (n=134), LUSC (n=501) and LUAD (n=513) patients with differential level of NRP1 expression. (E) Survival curve of LUSC and LUAD patients with differential level of TMPRSS2 expression. Analysis was done with Kaplan-Meier Plotter.